Metropolitan Life Insurance Company (MetLife)’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,431
| Closed | -$43.9K | – | 174 |
|
|
2024
Q1 | $43.9K | Sell |
4,431
-320
| -7% | -$3.17K | ﹤0.01% | 1471 |
|
|
2023
Q4 | $15.3K | Buy |
4,751
+1,932
| +69% | +$6.24K | ﹤0.01% | 2029 |
|
|
2023
Q3 | $15K | Hold |
2,819
| – | – | ﹤0.01% | 2029 |
|
|
2023
Q2 | $26.9K | Buy |
2,819
+1,063
| +61% | +$10.1K | ﹤0.01% | 1774 |
|
|
2023
Q1 | $19.3K | Sell |
1,756
-710
| -29% | -$7.81K | ﹤0.01% | 1900 |
|
|
2022
Q4 | $36.5K | Hold |
2,466
| – | – | ﹤0.01% | 1670 |
|
|
2022
Q3 | $47.1K | Buy |
2,466
+337
| +16% | +$6.44K | ﹤0.01% | 1495 |
|
|
2022
Q2 | $45.4K | Buy |
2,129
+424
| +25% | +$9.04K | ﹤0.01% | 1567 |
|
|
2022
Q1 | $32.8K | Sell |
1,705
-6,170
| -78% | -$119K | ﹤0.01% | 1831 |
|
|
2021
Q4 | $163K | Hold |
7,875
| – | – | ﹤0.01% | 2158 |
|
|
2021
Q3 | $188K | Hold |
7,875
| – | – | ﹤0.01% | 2122 |
|
|
2021
Q2 | $215K | Buy |
7,875
+2,215
| +39% | +$60.4K | ﹤0.01% | 2095 |
|
|
2021
Q1 | $164K | Hold |
5,660
| – | – | ﹤0.01% | 2157 |
|
|
2020
Q4 | $159K | Hold |
5,660
| – | – | ﹤0.01% | 2092 |
|
|
2020
Q3 | $166K | Buy |
5,660
+1,883
| +50% | +$55.2K | ﹤0.01% | 1899 |
|
|
2020
Q2 | $114K | Hold |
3,777
| – | – | ﹤0.01% | 2175 |
|
|
2020
Q1 | $113K | Buy |
+3,777
| New | +$113K | ﹤0.01% | 1958 |
|